CN Patent

CN121816193A — 用于递送疟原虫抗原的组合物及相关方法

Assigned to Biotechnology Europe Inc · Expires 2026-04-07 · 0y expired

What this patent protects

本公开提供了用于递送疟疾蛋白抗原的组合物(例如，药物组合物)和相关技术(例如，其组分和/或与其相关的方法)。此外，本公开提供了编码疟疾蛋白抗原的多聚核糖核苷酸。

USPTO Abstract

本公开提供了用于递送疟疾蛋白抗原的组合物(例如，药物组合物)和相关技术(例如，其组分和/或与其相关的方法)。此外，本公开提供了编码疟疾蛋白抗原的多聚核糖核苷酸。

Drugs covered by this patent

Patent Metadata

Patent number
CN121816193A
Jurisdiction
CN
Classification
—
Expires
2026-04-07
Drug substance claim
No
Drug product claim
No
Assignee
Biotechnology Europe Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.